Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.

Voskuil DW, Vrieling A, Korse CM, Beijnen JH, Bonfrer JM, van Doorn J, Kaas R, Oldenburg HS, Russell NS, Rutgers EJ, Verhoef S, van Leeuwen FE, van't Veer LJ, Rookus MA.

Nutr Cancer. 2008;60(3):342-53. doi: 10.1080/01635580701861777.

PMID:
18444168
2.

Physical activity and biomarkers in breast cancer survivors: a systematic review.

Löf M, Bergström K, Weiderpass E.

Maturitas. 2012 Oct;73(2):134-42. doi: 10.1016/j.maturitas.2012.07.002. Epub 2012 Jul 26. Review.

PMID:
22840658
3.

In-utero exposures and breast cancer risk: joint effect of estrogens and insulin-like growth factor?

Schernhammer ES.

Cancer Causes Control. 2002 Aug;13(6):505-8. Review.

PMID:
12195639
4.

The role of lycopene and its derivatives in the regulation of transcription systems: implications for cancer prevention.

Sharoni Y, Linnewiel-Hermoni K, Zango G, Khanin M, Salman H, Veprik A, Danilenko M, Levy J.

Am J Clin Nutr. 2012 Nov;96(5):1173S-8S. doi: 10.3945/ajcn.112.034645. Epub 2012 Oct 10. Review.

5.

IGF system components as prognostic markers in breast cancer.

Lee AV, Hilsenbeck SG, Yee D.

Breast Cancer Res Treat. 1998 Feb;47(3):295-302. Review.

PMID:
9516083
6.

IGF-I physiology and breast cancer.

Pollak M.

Recent Results Cancer Res. 1998;152:63-70. Review.

PMID:
9928547

Supplemental Content

Support Center